FSNUY on OTC

Fresenius SE & Co. KGaA

Logo: Fresenius SE & Co. KGaA, Public domain, via Wikimedia Commons4

German health company

Fresenius SE & Co. KGaA is a German multinational health care company based in Bad Homburg vor der Höhe.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

1981Founded1

Compare with another stock.

  • TickerFSNUY on OTC1
  • Industryhealth care industry, pharmaceutical industry1
  • HeadquartersBad Homburg vor der Höhe1
  • Websitewww.fresenius.de
  • Legal formSE & Co. KGaA1
  • Listed onFrankfurt Stock Exchange (FRE), OTC Markets Group (FSNUF)1
  • Incorporated inGermany5
  • Business addressElse-Kroener Strasse 1, Bad Homburg, 2M 613465
Bad Homburg Fresenius Zentrale
Photo: Karsten11, Public domain, via Wikimedia Commons6

Fresenius SE & Co. KGaA is a German multinational health care company based in Bad Homburg vor der Höhe. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities. The company was ranked 411th in the 2023 Forbes Global 2000 list.3

The story

Founded by Eduard Fresenius in 1981.1

Leadership

Who has led Fresenius SE & Co. KGaA, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Michael Sen2022–now
1990200020102020

Products and brands

  • infusion pump

Listed on Wikidata.1

Subsidiaries and ownership

Owners

  • Allianz Global Investors
  • BlackRock
  • Capital Group Companies
  • Else Kröner-Fresenius-Foundation
  • Henderson Group

Subsidiaries

  • Fresenius Helios
  • Fresenius Kabi
  • Fresenius Kabi (Czechia)
  • Fresenius Kabi (United States)
  • Fresenius Medical Care
  • Fresenius Medical Care - DS

From Wikidata.1

Acquisitions

  1. Succeeded Fresenius SE1

Employees over time

Fresenius SE & Co. KGaA employees by year1176.5K in 2024−43% since 2020
0100.0K200.0K300.0K400.0K2020: 311.3K311.3K20202021: 316.1K316.1K2021+2%2022: 316.9K316.9K2022+0%2023: 193.9K193.9K2023−39%2024: 176.5K176.5K2024−9%
  • 2024176,4861
  • 2023193,8651
  • 2022316,9201
  • 2021316,0781
  • 2020311,2691

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

Fresenius SE & Co. KGaA revenue by year121.5B EUR in 2024−41% since 2020
020.0B EUR40.0B EUR60.0B EUR2020: 36.3B EUR36.3B EUR20202021: 37.5B EUR37.5B EUR2021+3%2022: 40.8B EUR40.8B EUR2022+9%2023: 22.3B EUR22.3B EUR2023−45%2024: 21.5B EUR21.5B EUR2024−3%
  • 202421.5B EUR1
  • 202322.3B EUR1
  • 202240.8B EUR1
  • 202137.5B EUR1
  • 202036.3B EUR1

Former names

  • FRESENIUS SEJul 29, 2008 to Jul 29, 20085
  • FRESENIUS AKTIENGESELLSCHAFTJul 23, 1996 to Oct 20, 20065

Timeline

  1. Oct 2022New chief executive Michael Sen becomes CEO1
  2. 1981Founded Founded1

Recent filings

  1. Jan 8, 2019SC 13D/A
  2. May 4, 2017SC 13D
  3. May 4, 20173
  4. Jul 22, 2014F-6 POS
  5. Oct 26, 2011EFFECT
  6. Oct 19, 2011F-6
  7. Oct 20, 2006NO ACT AUTO-GENERATED PAPER DOCUMENT
  8. Sep 18, 1998SC 13D/A SCHEDULE 13D/A
  9. Jul 15, 1998SC 13D/A AMENDMENT #7 TO SCHEDULE 13D
  10. Nov 3, 1997SC 13D/A AMENDMENT #6 TO SCHEDULE 13D
  11. Aug 14, 1997SC 13D/A AMENDED SC 13D
  12. May 7, 1997SC 13D/A AMENDMENT TO SCHEDULE 13D
  13. Dec 23, 1996SC 13D/A SCHEDULE 13D/A AMENDMENT #3
  14. Jul 23, 1996SC 13D/A AMENDMENT NO. 16 TO SCHEDULE 13D
  15. Jul 3, 1996SC 13D/A AMENDMENT NO. 15 TO SCHEDULE 13D

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2